Advanced

AJNR - American Journal of Neuroradiology

Published ahead of print on April 2, 2009
doi: 10.3174/ajnr.A1583

This Article Figures Only Full Text Full Text (PDF) Supplemental Online Table All Versions of this Article: ajnr.A1583v1 30/7/1342    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Google Scholar Articles by Wang, C. Articles by Mao, B. PubMed PubMed Citation Articles by Wang, C. Articles by Mao, B.

American Journal of Neuroradiology 30:1342-1346, August 2009
© 2009 American Society of Neuroradiology

INTERVENTIONAL

Placement of Covered Stents for the Treatment of Direct Carotid Cavernous Fistulas

C. Wang^a, X. Xie^a, C. You^a, C. Zhang^a, M. Cheng^a, M. He^a, H. Sun^a and B. Mao^a

^a From the Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, P.R. China

Please address correspondence to Xiaodong Xie, MD, or Chaohua Wang, MD, Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, P.R. China, 610041; e-mail: xiaodong_1962{at}163.com or chaohuawang{at}sina.com

BACKGROUND AND PURPOSE: Endovascular detachable balloon occlusion and coil occlusion are 2 well-established options for the treatment of direct carotid cavernous fistulas (DCCFs). In recent years, covered stents have been applied in the treatment of neurovascular pathologies such as aneurysms, pseudoaneurysms, arterial dissections, and DCCFs. The purpose of this study was to investigate the clinical efficacy of covered stents for the treatment of DCCFs.

MATERIALS AND METHODS: Ten consecutive patients underwent covered-stent placement after failure of detachable balloon occlusion for the treatment of their DCCFs. Clinical and angiographic follow-up ranged from 5 to 48 months (mean, 18.2 months) after stent placement.

RESULTS: Stent placement was technically successful in all except 1 patient. In this patient, stent placement failed after multiple attempts because of rigidity of the Jostent GraftMaster Coronary Stent Graft and the tortuous anatomy of the internal carotid artery (ICA). Complete exclusion of the fistula was achieved in 6 patients immediately after stent deployment. Endoleak was observed in 3 patients. Re-dilation of the stent avoided the endoleak in 2 patients; in 1 of these 2 patients, formerly improved symptoms recurred the next morning and the ipsilateral ICA was occluded with detachable balloons. Spasm of the ICA was observed in most of the patients after stent placement; however, angioplasty was not required. Symptoms improved in all patients after treatment, without thromboembolic events. Follow-up cerebral angiography showed complete exclusion of all DCCFs and stent patency without intrastent stenosis in the 8 patients who had successful deployment of the stent.

CONCLUSIONS: Although a larger sample and expanded follow-up are needed, our series shows that covered stents can be used in the treatment of DCCFs with symptomatic relief.